Literature DB >> 7548174

Fermentable carbohydrates exert a more potent cholesterol-lowering effect than cholestyramine.

M L Favier1, C Moundras, C Demigné, C Rémésy.   

Abstract

The purpose of this work was to assess the respective role of bile acid excretion and of the end-products of cecal fermentations in the cholesterol-lowering effect of complex carbohydrates. The effects of two different fermentable carbohydrates (guar gum, beta-cyclodextrin), and sequestrant resin (cholestyramine) have been investigated in male Wistar rats. Guar gum and beta-cyclodextrin are broken down in the large bowel, with fermentation rich in propionic acid (37% against 26% for control), whereas cholestyramine did not enhance cecal fermentation. beta-Cyclodextrin and guar gum were less potent than cholestyramine to enhance bile acids and sterol excretion. Nevertheless, fermentable carbohydrates exerted a more potent cholesterol-lowering effect than cholestyramine. beta-Cyclodextrin also depressed triacylglycerol-rich lipoprotein (TGRLP). Fermentable carbohydrates lowered cholesterol of LDL and HDL1 fractions. The induction of hepatic HMG-CoA reductase was practically proportional to rate of fecal steroid excretion. Moreover, with beta-cyclodextrin, hepatic HMG-CoA reductase induction was concomitant to a decrease in fatty acid synthase (FAS) activity. Thus, the cholesterol-lowering effect of fermentable carbohydrates could be related to a depressed lipogenesis, as well as to an accelerated removal of HDL1, in relation to an elevated hepatic demand of cholesterol. In conclusion, fermentable carbohydrates could favour cholesterol elimination and have a general lipid-lowering effect by exerting more complex physiological effects than cholestyramine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548174     DOI: 10.1016/0005-2760(95)00107-n

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Ye Chen; Boris L Vaisman; Marcelo J Amar; Milton Pryor; Seth G Thacker; Xue Zhang; Xujing Wang; Yubo Zhang; Jun Zhu; Zhi-Hong Yang; Lita A Freeman; Alan T Remaley
Journal:  Mol Nutr Food Res       Date:  2017-02-24       Impact factor: 5.914

2.  Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?

Authors:  Lorenza Conterno; Francesca Fava; Roberto Viola; Kieran M Tuohy
Journal:  Genes Nutr       Date:  2011-05-11       Impact factor: 5.523

3.  The cholesterol-lowering effect of guar gum in rats is not accompanied by an interruption of bile acid cycling.

Authors:  M L Favier; P E Bost; C Demigné; C Rémésy
Journal:  Lipids       Date:  1998-08       Impact factor: 1.880

Review 4.  Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

Authors:  Lay-Gaik Ooi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2010-06-17       Impact factor: 5.923

5.  Effects of a polysaccharide-rich extract derived from Irish-sourced Laminaria digitata on the composition and metabolic activity of the human gut microbiota using an in vitro colonic model.

Authors:  Conall R Strain; Kenneth C Collins; Violetta Naughton; Emeir M McSorley; Catherine Stanton; Thomas J Smyth; Anna Soler-Vila; Mary C Rea; Paul R Ross; Paul Cherry; Philip J Allsopp
Journal:  Eur J Nutr       Date:  2019-02-25       Impact factor: 5.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.